Publications by authors named "Yating Dian"

Claim this Profile
I
Immune checkpoint inhibitors in cancer patients with autoimmune disease: Safety and efficacy.
Jiayuan Le, Yuming Sun, Guangtong Deng, Yating Dian, Yanli Xie

Hum Vaccin Immunother· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vorapaxar enhanced mitochondria-associated ferroptosis primes cancer immunotherapy via targeting FOXO1/HMOX1 axis.
Qian Zhou, Yuming Sun, Songtao Du, Yating Dian, Lei Yao

Cell Rep Med· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single-cell multi-omics in cancer immunotherapy: from tumor heterogeneity to personalized precision treatment.
Jiayuan Le, Yating Dian, Deze Zhao, Ziyu Guo, Zehao Luo

Mol Cancer· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting oxidative stress-mediated regulated cell death as a vulnerability in cancer.
Danyao Chen, Ziyu Guo, Lei Yao, Yuming Sun, Yating Dian

Redox Biol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Ferroptosis: A Targetable Vulnerability for Melanoma Treatment.
Yu Meng, Qian Zhou, Yating Dian, Furong Zeng, Guangtong Deng

J Invest Dermatol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The molecular mechanism and therapeutic landscape of copper and cuproptosis in cancer.
Ziyu Guo, Danyao Chen, Lei Yao, Yuming Sun, Daishi Li, Yating Dian

Signal Transduct Target Ther· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of survival in immunotherapy-based treatments in advanced melanoma: a meta-analysis.
Daishi Li, Yuming Sun, Jiayuan Le, Yating Dian, Yihuang Liu

Int J Dermatol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating the causal effect of using glucagon-like peptide-1 receptor agonists on the risk of autoimmune diseases.
Yuming Sun, Qian Zhou, Lorraine Edna Onzere, Yating Dian, Yu Meng

Diabetes Metab Syndr· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical characteristics and risk factors for ZF2001 fully vaccinated inpatients with COVID-19: A retrospective cohort study.
Liping Jin, Yating Dian, Yuming Sun, Guangtong Deng, Chaofei Han

Hum Vaccin Immunother· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of tebentafusp in patients with metastatic uveal melanoma: A systematic review and meta-analysis.
Yating Dian, Yihuang Liu, Furong Zeng, Yuming Sun, Guangtong Deng

Hum Vaccin Immunother· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to comment on: "Efficacy and safety of tebentafusp in patients with metastatic uveal melanoma: A systematic review and meta-analysis".
Danyao Chen, Yuming Sun, Yating Dian, Guangtong Deng

Hum Vaccin Immunother· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Ferroptosis: mechanisms and therapeutic targets.
Qian Zhou, Yu Meng, Jiayuan Le, Yuming Sun, Yating Dian

MedComm (2020)· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Propafenone facilitates mitochondrial-associated ferroptosis and synergizes with immunotherapy in melanoma.
Qian Zhou, Yating Dian, Yi He, Lei Yao, Hui Su

J Immunother Cancer· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of glucagon-like peptide-1 receptor agonists with risk of cancers-evidence from a drug target Mendelian randomization and clinical trials.
Yuming Sun, Yongjia Liu, Yating Dian, Furong Zeng, Guangtong Deng

Int J Surg· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Ubiquitin-specific protease 22 controls melanoma metastasis and vulnerability to ferroptosis through targeting SIRT1/PTEN/PI3K signaling.
Huiyan Sun, Yu Meng, Lei Yao, Songtao Du, Yayun Li, Yating Dian

MedComm (2020)· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of eosinopenia with worsening prognosis in hospitalized Azvudine-treated COVID-19 patients: a retrospective cohort study.
Xiaomin Wang, Yating Dian, Qian Zhou, Guangtong Deng, Rui Wei

Front Immunol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular landmarks of tumor disulfidptosis across cancer types to promote disulfidptosis-target therapy.
Deze Zhao, Yu Meng, Yating Dian, Qian Zhou, Yuming Sun

Redox Biol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lactate dehydrogenase predicts disease progression outcome in COVID-19 patients treated with Azvudine.
Manyun Mao, Yating Dian, Yuming Sun, Wangqing Chen, Wu Zhu

Front Cell Infect Microbiol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunophenotyping characteristics and outcome of COVID-19 patients: peripheral blood CD8+T cell as a prognostic biomarker for patients with Nirmatrelvir.
Yuming Sun, Yating Dian, Qian Gao, Guangtong Deng

Front Immunol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Elevated troponin levels predict the reduced efficacy of Paxlovid in COVID-19 patients.
Deze Zhao, Yi He, Yating Dian, Yu Meng, Furong Zeng

J Infect· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Azvudine versus Paxlovid for oral treatment of COVID-19 in Chinese patients with pre-existing comorbidities.
Yating Dian, Yu Meng, Yuming Sun, Guangtong Deng, Furong Zeng

J Infect· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to 'Oral Azvudine for hospitalised patients with COVID-19 and pre-existing conditions: a retrospective cohort study.' [EClinicalMedicine 59 (2023) 101981].
Yuming Sun, Liping Jin, Yating Dian, Minxue Shen, Furong Zeng

EClinicalMedicine· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oral Azvudine for hospitalised patients with COVID-19 and pre-existing conditions: a retrospective cohort study.
Yuming Sun, Liping Jin, Yating Dian, Minxue Shen, Furong Zeng

EClinicalMedicine· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world effectiveness of Azvudine versus nirmatrelvir-ritonavir in hospitalized patients with COVID-19: A retrospective cohort study.
Guangtong Deng, Daishi Li, Yuming Sun, Liping Jin, Qian Zhou, Yating Dian

J Med Virol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Lipid Droplets and Perilipins in Cardiovascular Diseases].
Ya-Ting Dian, Yang Yang, Ping Zhu, Ming-Yi Zhao

Zhongguo Yi Xue Ke Xue Yuan Xue Bao· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis